Cribstone Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-47,349
| Closed | -$841K | – | 785 |
|
|
2018
Q3 | $841K | Hold |
47,349
| – | – | 0.39% | 63 |
|
|
2018
Q2 | $653K | Hold |
47,349
| – | – | 0.32% | 65 |
|
|
2018
Q1 | $430K | Hold |
47,349
| – | – | 0.21% | 85 |
|
|
2017
Q4 | $203K | Hold |
47,349
| – | – | 0.1% | 128 |
|
|
2017
Q3 | $67K | Hold |
47,349
| – | – | 0.03% | 220 |
|
|
2017
Q2 | $71K | Buy |
47,349
+19,208
| +68% | +$28.8K | 0.04% | 222 |
|
|
2017
Q1 | $66K | Hold |
28,141
| – | – | 0.04% | 246 |
|
|
2016
Q4 | $63K | Sell |
28,141
-19,208
| -41% | -$43K | 0.04% | 233 |
|
|
2016
Q3 | $142K | Hold |
47,349
| – | – | 0.09% | 138 |
|
|
2016
Q2 | $152K | Buy |
47,349
+14,808
| +46% | +$47.5K | 0.09% | 132 |
|
|
2016
Q1 | $101K | Hold |
32,541
| – | – | 0.08% | 101 |
|
|
2015
Q4 | $130K | Buy |
+32,541
| New | +$130K | 0.11% | 99 |
|